Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
1(7%)
Results Posted
9%(1 trials)

Phase Distribution

Ph not_applicable
4
29%
Ph phase_4
3
21%
Ph phase_2
2
14%
Ph early_phase_1
5
36%

Phase Distribution

5

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution14 total trials
Early Phase 1First-in-human
5(35.7%)
Phase 2Efficacy & side effects
2(14.3%)
Phase 4Post-market surveillance
3(21.4%)
N/ANon-phased studies
4(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(11)
Terminated(1)

Detailed Status

Completed11
Not yet recruiting1
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 15 (35.7%)
Phase 22 (14.3%)
Phase 43 (21.4%)
N/A4 (28.6%)

Trials by Status

completed1179%
not_yet_recruiting17%
withdrawn17%
recruiting17%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
DRUG
Total Trials
14